These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19352582)

  • 1. Recombinant activated factor VII to control life-threatening haemorrhagic radiation cystitis.
    Connolly SS; D'Arcy FT; Corcoran MO
    Ir J Med Sci; 2010 Sep; 179(3):431-3. PubMed ID: 19352582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa to treat late radiation-induced hemorrhagic cystitis: a case report.
    Geisler JP; Linnemeier GC; Manahan KJ
    J Reprod Med; 2008 May; 53(5):360-2. PubMed ID: 18567283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation.
    Karimi M; Zakerinia M; Khojasteh HN; Ramzi M; Ahmad E
    J Thromb Haemost; 2004 Oct; 2(10):1853-5. PubMed ID: 15456505
    [No Abstract]   [Full Text] [Related]  

  • 4. [Using recombinant activated blood coagulation factor VII for treatment of hemorrhagic syndrome in patients with thrombocytopenia].
    Galstian GM; Kolosova IV
    Anesteziol Reanimatol; 2014; 59(6):60-6. PubMed ID: 25831706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recombinant activated Factor VII (Novo Seven) for uncontrollable hemorrhage in critically ill patients with multiple injuries].
    Pernazza F; Olearis A
    Minerva Chir; 2004 Apr; 59(2):XVII-XIX. PubMed ID: 15455479
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravesical formalin for the control of intractable bladder haemorrhage secondary to radiation cystitis or bladder cancer.
    Likourinas M; Cranides A; Jiannopoulos B; Kostakopoulos A; Dimopoulos C
    Urol Res; 1979 Jun; 7(2):125-6. PubMed ID: 573008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiographic documentation of the efficacy of recombinant activated factor VII (NovoSeven) to control diffuse bleeding in major trauma.
    Van Der Schueren B; Hammer F; Verschuren F; Hantson P; Deneys V; Hermans C
    Thromb Haemost; 2005 Dec; 94(6):1327-8. PubMed ID: 16411413
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrapulmonary Recombinant Factor VII as an Effective Treatment for Diffuse Alveolar Hemorrhage: A Case Series.
    Baker MS; Diab KJ; Carlos WG; Mathur P
    J Bronchology Interv Pulmonol; 2016 Jul; 23(3):255-8. PubMed ID: 27261934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy.
    Ashrani AA; Gabriel DA; Gajewski JL; Jacobs DR; Weisdorf DJ; Key NS
    Bone Marrow Transplant; 2006 Dec; 38(12):825-8. PubMed ID: 17133240
    [No Abstract]   [Full Text] [Related]  

  • 10. Activated recombinant factor VII in the treatment of retroperitoneal haemorrhage in a patient with factor VIII inhibitor.
    Ng SC
    Ann Acad Med Singap; 1994 Nov; 23(6):901-2. PubMed ID: 7741509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of activated recombinant factor VII (rFVIIa, NovoSeven) in neonatology].
    Georgieva R
    Akush Ginekol (Sofiia); 2008; 47(3):46-50. PubMed ID: 18756832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced haemorrhagic cystitis.
    Crew JP; Jephcott CR; Reynard JM
    Eur Urol; 2001 Aug; 40(2):111-23. PubMed ID: 11528186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of prednisolone therapy for radiation-induced hemorrhagic cystitis].
    Yanagi M; Nishimura T; Kurita S; Lee C; Kondo Y; Yamazaki K
    Nihon Hinyokika Gakkai Zasshi; 2011 May; 102(3):600-2. PubMed ID: 21846069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy.
    Chuansumrit A; Nuntnarumit P; Okascharoen C; Teeraratkul S; Suwansingh S; Supapannachart S
    Pediatrics; 2002 Jul; 110(1 Pt 1):169-71. PubMed ID: 12093965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of recombinant activated factor VII in diffuse alveolar haemorrhage].
    Dabar G; Harmouche C; Jammal M
    Rev Mal Respir; 2011 Jan; 28(1):106-11. PubMed ID: 21277485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant activated factor VII in critical bleeding: clinical experience of a single center.
    Sartori MT; Imbergamo S; Zanon E; Bonaccorso G; Pittoni G; Feltracco P; Ori C; Pagnan A; Cella G
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):628-35. PubMed ID: 19605376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant factor VIIa for major haemorrhage.
    Pugh RJ; Wenstone R; Martlew VJ; Marx G
    Eur J Anaesthesiol; 2005 Jul; 22(7):548-50. PubMed ID: 16045146
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravesical instillation of Formalin for hemorrhagic cystitis secondary to radiation for gynecologic malignancies.
    Behnam K; Patil UB; Mariano E
    Gynecol Oncol; 1983 Aug; 16(1):31-3. PubMed ID: 6884828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of recombinant factor VIIa for life-threatening bleeding in a patient with severe necrotizing pancreatitis.
    Borrás-Blasco J; Conesa-García V; Navarro-Ruiz A; Palacios-Ortega F; Gómez A
    Pancreas; 2005 Oct; 31(3):292-4. PubMed ID: 16163065
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant activated factor VII--"lifesaving or surgeon correcting"?
    Koci J; Dedek T; Havel E; Trlica J
    J Trauma; 2011 Feb; 70(2):523-4; author reply 524-5. PubMed ID: 21307759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.